David James Lennon - 02 Oct 2024 Form 4 Insider Report for Aadi Bioscience, Inc. (AADI)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ /s/ Stephen Rodin, as Attorney-in-Fact
Issuer symbol
AADI
Transactions as of
02 Oct 2024
Transactions value $
-$18,797
Form type
4
Filing time
03 Oct 2024, 19:03:40 UTC
Previous filing
04 Mar 2024
Next filing
03 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AADI Common Stock Options Exercise $0 +32.6K $0.00 32.6K 02 Oct 2024 Direct F1
transaction AADI Common Stock Sale -$18.8K -9.69K -29.76% $1.94 22.9K 03 Oct 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AADI Restricted Stock Units Options Exercise $0 -32.6K -100% $0.00 0 02 Oct 2024 Common Stock 32.6K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.
F2 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F3 One hundred percent (100%) of the RSUs subject to the award vested on October 2, 2024.

Remarks:

Exhibit 24 - Power of Attorney